Contemporary Therapeutic Strategies in Advanced Non-Small Cell Lung Cancer
Wednesday, August 13, 2008
Los Angeles, California
TARGET AUDIENCE
This educational activity is intended for oncologists, radiologists, thoracic surgeons, pulmonologists and other physicians in active clinical practice interested and/or involved in the management of patients with non-small cell lung cancer.
CONTINUING MEDICAL EDUCATION
Imedex, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Imedex, LLC designates this educational activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)TM Physicians should only claim credit commensurate with the extent of their participation in the activity.
LEARNING OBJECTIVES
After attending this symposium, participants should be able to:
- Discuss the heterogeneous nature of stage III NSCLC and define subclasses within this broad group of tumors.
- Explain the role of surgery and radiotherapy in the management of locally advanced NSCLC.
- Evaluate clinical evidence for combined modality therapy in locally advanced and advanced NSCLC.
- Determine appropriate management options for advanced NSCLC, including the incorporation of newer therapeutic agents.
David Jablons. MD |
Vivek Mehta, MD |
Ronald Natale, MD |
6:30 pm
Reception
6:45 pm
Introduction
7:00 pm – 8:20 pm
Clinical Challenges in Stage III NSCLC
7:00 pm
Surgical Evaluation in Stage III NSCLC
David Jablons, MD
7:20 pm
Recent Advances in Radiation Therapy
Vivek Mehta, MD
7:40 pm
Combined Modality Therapy
Ronald Natale, MD
8:00 pm
Panel Discussion
8:20 pm
Emerging Data in Advanced NSCLC
Ronald Natale, MD
8:45 pm
Discussion
9:00 pm
Adjourn
This is a complimentary educational dinner meeting for physicians. There is no cost to attend this activity or to obtain CME credits. You may register online at www.imedex.com.
MEETING LOCATION:
Grace
7360 Beverly Boulevard
Los Angeles, California
Tel.: (323) 934 4400
SERIES CHAIR:
Ramaswamy Govindan, MD
Washington University in St. Louis
School of Medicine
St. Louis, Missouri
ORGANIZER:
Imedex
11675 Rainwater Drive, Suite 600
Alpharetta, GA 30009, USA
Tel.: +1 (770) 751 7332
Fax: +1 (770) 751 7334
Email: meetings@imedex.com
Web: www.imedex.com
Imedex is a brand and assumed name used by Imedex, LLC (hereby referred to as Imedex). Imedex is solely responsible for this agenda’s content. Although Imedex attempts to ensure that the information in our program is accurate and timely, matters and opinions discussed and/or presented with respect to clinical matters are those of the discussion participants only, and not necessarily those of Imedex. Moreover, although Imedex attempts to identify and integrate the most qualified medical professionals in our program, TO THE FULLEST EXTENT PERMITTED BY LAW, IMEDEX EXPRESSLY DISCLAIM ALL WARRANTIES, EITHER EXPRESS OR IMPLIED, STATUTORY OR OTHERWISE, INCLUDING BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY, NON-INFRINGEMENT OF THIRD PARTIES’ RIGHTS, AND FITNESS FOR A PARTICULAR PURPOSE, WITH RESPECT TO THE CONTENT PRESENTED. IMEDEX FURTHER MAKES NO REPRESENTATIONS OR WARRANTIES ABOUT THE ACCURACY, RELIABILITY, COMPLETENESS OR TIMELINESS OF THE CONTENT OR ANY MATERIAL PRESENTED.
In addition, the material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.
Neither Imedex nor any of its subsidiaries or affiliates is affiliated with or formally endorsed by a medical society.
©2008 Imedex®, LLC. All rights reserved.
Reproduction in whole or part is prohibited without prior written consent from Imedex and contributing faculty.
The following companies
have provided unrestricted
educational grants in support
of this series:
Genentech BioOncology and OSI Oncology
